Gelion PLC (GB:GELN)
LSE:GELN
Want to see GB:GELN full AI Analyst Report?
GELN Stock Chart & Stats
18.50 p
1.00 p(6.25%)
At close: 4:00 PM EST
18.50 p
1.00 p(6.25%)
Day’s Range― - ―
52-Week Range10.50 p - 30.00 p
Previous CloseN/A
Volume5.00K
Average Volume (3M)395.75K
Market Cap
£39.00M
Enterprise Value19.62M
Total Cash (Recent Filing)£10.52M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.03
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding229,421,460
10 Day Avg. Volume121,404
30 Day Avg. Volume395,753
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)3.53
Price to Sales (P/S)38.63
P/FCF Ratio-7.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Successful Prototyping With Strategic PartnersThird-party pouch-cell prototyping with TDK and QinetiQ provides external validation of Gelion's NES chemistry and accelerates de-risking of cell-level performance. Durable partner-led validation improves prospects for scale-up, shortens commercialization timelines, and enhances credibility with potential customers and manufacturers.
CAM Scale-up To Commercial Aerial DensityAchieving commercial aerial density for cathode material is a structural manufacturing milestone: it signals process transfer beyond lab scale, enables higher energy-per-area cells, and lays groundwork for volume supply. This materially improves potential unit economics once yields and downstream integration are proven.
Conservative Leverage And Focus On Non-dilutive FundingMinimal debt reduces insolvency and interest burden, giving management flexibility to fund technical development. Combined with an emphasis on ARENA and other grants, this preserves upside for equity holders while enabling targeted capex and pilot projects without immediate reliance on dilutive capital or expensive borrowings.
Bears Say
Persistent Negative Operating And Free Cash FlowSustained cash burn means Gelion remains dependent on external funding to finance operations and scale manufacturing. Over a multi-quarter horizon this increases execution and dilution risk, constrains strategic optionality, and raises pressure to convert technical milestones into paying customers to achieve cash-flow breakeven.
Very Small, Volatile Revenue And Delayed Commercial SalesTiny, inconsistent revenues and a stated absence of integration revenue in 2026 mean fixed costs will continue to outstrip sales. Long sales cycles and deferred commercialization elongate the path to margin expansion, making profitability contingent on multi-year execution and customer adoption rather than near-term operational tweaks.
Remaining Technical And Partner Execution RisksUnproven long-term calendar life, required yield/process engineering, and partner disruptions are structural execution risks. They can materially delay commercial ramps, increase unit costs, and require further capital and engineering cycles before cell-level economics and customer acceptance are achieved.
Gelion PLC News
GELN FAQ
What was Gelion PLC’s price range in the past 12 months?
Gelion PLC lowest share price was 10.50 p and its highest was 30.00 p in the past 12 months.
What is Gelion PLC’s market cap?
Gelion PLC’s market cap is £39.00M.
When is Gelion PLC’s upcoming earnings report date?
Gelion PLC’s upcoming earnings report date is Nov 11, 2026 which is in 189 days.
How were Gelion PLC’s earnings last quarter?
Gelion PLC released its earnings results on Mar 02, 2026. The company reported -0.017 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.017 p.
Is Gelion PLC overvalued?
According to Wall Street analysts Gelion PLC’s price is currently Overvalued.
Does Gelion PLC pay dividends?
Gelion PLC does not currently pay dividends.
What is Gelion PLC’s EPS estimate?
Gelion PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelion PLC have?
Gelion PLC has 229,421,460 shares outstanding.
What happened to Gelion PLC’s price movement after its last earnings report?
Gelion PLC reported an EPS of -0.017 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of Gelion PLC?
Currently, no hedge funds are holding shares in GB:GELN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gelion PLC Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.31%
12-Months-Change
Fundamentals
Return on Equity
-42.23%
Trailing 12-Months
Asset Growth
59.13%
Trailing 12-Months
Company Description
Gelion PLC
Gelion plc engages in the research and development, design, manufacture, and sale of battery systems in the United Kingdom and internationally. The company offers zinc-bromide batteries under the Endure name. Its products are used in various applications, which include industrial light towers, solar and wind farms, desalination plants, mining pumps, passenger and heavy vehicles, electric buses and trains, and irrigation systems and other agricultural applications, as well as used by commercial and industrial enterprises and grid operators. The company was incorporated in 2015 and is headquartered in Eveleigh, Australia.
Technical Analysis
Options Prices
Currently, No data available
---